Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-28
1995-08-22
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514266, A61K 3152
Patent
active
054440637
ABSTRACT:
A method and composition for the treatment of humans infected with HBV that includes the administration of an HBV treatment amount of a .beta.-dioxolanyl purine nucleoside of the formula: ##STR1## wherein R is OH, Cl, NH.sub.2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.
REFERENCES:
patent: 4000137 (1976-12-01), Dvonoch et al.
patent: 4336381 (1982-06-01), Nagata et al.
patent: 4861759 (1989-08-01), Mitsuya et al.
patent: 4879277 (1989-11-01), Mitsuya et al.
patent: 4916122 (1990-04-01), Chu et al.
patent: 4963533 (1990-10-01), de Clercq et al.
patent: 4968674 (1990-11-01), Taniyama et al.
patent: 5041449 (1991-08-01), Belleau et al.
patent: 5047407 (1991-09-01), Belleau
patent: 5059690 (1991-10-01), Zahler et al.
patent: 5204466 (1993-04-01), Liotta et al.
patent: 5210085 (1993-05-01), Liotta et al.
patent: 5270315 (1993-12-01), Belleau
Ralzarini, J., et al. "Potent and Selective Anti-HTI V-III/I AV Activity of 2', 3'-Dideoxycytidineen, the 2',3'-Unsaturated Derivative of 2',3'-Dideoxycytidine," Biochemical and Biophysical Research Communications, vol. 140, No. 2, pp. 735-742 (1986).
Belleau, B., et al., Abstracts of Papers, Fifth International Conference on AIDS, Montreal: International Research Centre; Ottawa, Ontario, 1989.
Carter, et al., "Activities of (-)-Carbovir and 3'-Azido-3'-Deoxythymidine Against Human Immunodeficiency Virus In Vitro," Antimicrobial Agents and Chemotherapy, vol. 34, No. 6, pp. 1297-1300 (1990).
Chu, et al., "Structure-Activity Relationships of Pyrimide Nucleosides as Antiviral Agents for Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells," J. Med. Chem. vol. 32, p. 612 (1989).
Chu, et al., "Comparative Activity of 2',3'-Saturated and Unsaturated Pyrimidine and Purine Nucleosides Against Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells," Biochem. Pharm., vol. 37, No. 19, pp. 3543-3548 (1988).
Chu, C. K. et al., "An Efficient Total Synthesis of 3'-Azido-3'-Deoxythiymidine (AZT) and 3'-Azido-2',3'-Dideoxyuridine (AZDDU CS-87) from D-Mannitol," Tetrahedron Lett. 1988, 5349.
Coates, J. A. V., et al., "The Separated Enantiomers of 2'-Deoxy-3'-Thiacytidine (BCH189) Both Inhibit Human Immunodeficiency Virus Replication In Vitro," Antimicrobial Agents and Chemotherapy, pp. 202-205 (1992).
Cretton, E., et al., "Pharmokinetics of 3'-Azido-3'-Dexoythymidine and its Catabolites and Interactions with Probenecid in Rhesus Monkeys," Antimicrobial Agents and Chemotherapy, pp. 801-807 (1991).
Cretton, E., et al., "Catabolims of 3'-Azido-3'-Deoxythymidine in Heptaocytes and Liver Microsomes, with Evidence of Formation of 3'-Amino-3'-Deoxythymidine, a Highly Toxic Catabolite for Human Bone Marrow Cells," Pharmacology, vol. 39, p. 258 (1991).
Furman, et al., "The Anti-Hepatitis B Virus Activities, Cytotxicities, and Anabolic Profiles of the (-) and (=) Enantiomers of cis-5-Fluoro-1,-[2-(Hydromethyl)-1,3-Oxthiolane-5-yl]Cytosine," Antimicrobial Agents and Chemotherapy, vol. 36, No. 12, pp. 2686-2692 (1992).
Jeong, K., et al., "Asymmetric Synthesis and Biological Evaluation of .beta.-L-(2R,5S)-and .alpha.-L-(2R-5R)-1,3-Oxathiolane-Pyrimidine and -Purine Nucleosides and Potential Anti-HIV Agents," J. Med. Chem., vol. 36 (1993).
Lin, et al., "Potent and Selective in Vitro Activity of 3'-Deoxythmindine-2-Ene-(3'-Deoxy-2',3'-Didehydrothymidine) Against Human Immunodeficiency Virus," Biochem. Pharm., vol. 36, No. 17, pp. 2716 (1987).
Mitsuya, H., et al., "Rapid in Vitro Systems, for Assessing Activity of Agents Against HTLV-III/LAV," AIDS: Modern Concepts and Therapeutic Challenges, S. Broder, Ed. (Marcel-Dekker, N.Y., 1987), p. 303.
Mitsuya, J., et al., "3'-Azido-3'-Deoxythymidine (BW A 509U): An Antiviral Agent that Inhibits and Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus In Vitro, Proc. Natl. Acad. Sci., USA," vol. 82, pp. 7097-7100 (1985).
Mitsuya, J., et al., "Molecular Targets for AIDS Therapy," Science, vol. 249, pp. 1533-1544 (1990).
Norbeck, D., et al., "A New 2',3'-Dideoxynucleoside Prototype with In Vitro Activity Against HIV," Tetrahedron Lett. 1989, 6263.
Okabe, M., et al., "Synthesis of the Dideoxynucleosides ddC and CNT from Glutamic Acid, Ribonolactone, and Pyrimidine Bases," J. Org. Chem. 1989.
Richman, D. D., et al., "The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex," N. Eng. J. Med. 1987, 317:192.
Satsumabayashi, S. et al., "The Synthesis of 1,3-Oxathiolane-5-one Derivaties," Bull. Chem. Soc. Japan, 1972, 45:913.
Schinazi, R. F., et al., "Activities of the Four Optical Isomers of 2',3'-Dideoxy-3'-Thiacytidine (BCH-189) against Human Immunodeficiency Virus Type 1 in Human Lymphocytes," Antimicrobial Agents and Chemotherapy 36(3) 672 676.
Schinazi, R. F., et al., "Insights into HIV Chemotherapy," AIDS Research and Human Retroviruses 8(6) (1992) 963-990 (1992).
Schinazi, R. F., et al., "Pharmacokinetics and Metabolism of Racemic 2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine in Rhesus Monkeys," Antimicrobial Agents and Chemotherapy 36(11) 2432-2438 (1992).
Schinazi, R. F., et al., "Selective Inhibition of Human Immunodeficiency Viruses by Racemates and Enantiomers of cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl)Cytosine," Antimicrobial Agents and Chemotherapy 36(11) 2423-2431 (1992).
Storer, Richard, et al., "The Resolution and Absolure Stereochemistry of the Enantiomers of cis-1[2-(Hydroxymethyl)-1,3-Oxthiolan-5-yl)Cytosine(BCH189): Equipotent Anti-HIV Agents," Nucleosides & Nucleotides, 12(2), 225-236 (1993).
Vorbruggen et al., "Nucleoside Synthesis with Trimethylsilyl Triflate and Perchlorate as Catalysts," Chem. Ver. 1981, 114:1234-1255.
Wilson, L. J., et al. "A General Method for Controlling Glycosylation Stereochemistry in the Synthesis of 2'-Deoxyribose Nucleosides," Tetrahedron Lett. 1990, 1815.
Zhu, Zhou, et al., "Cellular Metabolism of 3'-Azido-2',3'-Dideoxyuridine with Formation of 5'-O-Diphophoshexase Derivatives by Previously Unrecognized Metabolic Pathways of 2'-Deoxyuridine Analogs," Molecular Pharmacology, vol. 38, pp. 929-938 (1991).
Emory University
Peabody John
Richter Johann
Zalesky Cheryl K.
LandOfFree
Enantiomerically pure .beta.-D-dioxolane nucleosides with select does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomerically pure .beta.-D-dioxolane nucleosides with select, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomerically pure .beta.-D-dioxolane nucleosides with select will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2142002